DIRECTIONAL TRANSPORT OF MULV GLYCOPROTEINS

MULV糖蛋白的定向运输

基本信息

  • 批准号:
    3164990
  • 负责人:
  • 金额:
    $ 10.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1978
  • 资助国家:
    美国
  • 起止时间:
    1978-06-01 至 1990-06-30
  • 项目状态:
    已结题

项目摘要

Our objective is to define the molecular basis by which membrane glycoproteins are directionally transported to specific cellular locations. These investigations will be carried out using viral glycoproteins which are transported to different plasma membrane domains on surfaces of polarized epithelial cells. To identify sorting signals responsible for the directional transport of glycoproteins, we will analyze the effects of specific modifications and sequence substitutions on determining the cellular location of the resulting molecules. These studies will be carried out with viral glycoproteins which exhibit distinct orientations and transmembrane topology: the gp70/p15E glycoprotein of murine leukemia viruses, a bitopic membrane glycoprotein with a cleaved signal sequence that is anchored by hydrophobic residues near the C-terminus of the molecule, and the gPr-gag glycoprotein which is likely to be anchored to membranes in the opposite orientation. In order to characterize the intracellular transport pathway of MuLV glycoproteins, we will use specific antisera to identify transport vesicles involved in movement of glycoproteins from the Golgi complex to the plasma membrane. We will determine whether the two MuLV-encoded glycoproteins gp70/p15E and gPr-gag are present in the same population of transport vesicles and whether they are associated with one another on the plasma membrane. To further define the viral components which are involved in determining the maturation site of retroviruses in epithelial cells, we will investigate the site of virus assembly and release in cells which produce viral cores in the absence of viral glycoproteins, and determine the effects of supplementing these cells with viral glycoproteins directed to either the apical or basolateral membranes. In addition to providing a better understanding of basic cellular processes, the proposed studies should contribute to our knowledge concerning the pathogenesis of viral infections by elucidating the mechanisms by which viral components are targeted to particular locations.
我们的目标是确定膜的分子基础

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD W COMPANS其他文献

RICHARD W COMPANS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD W COMPANS', 18)}}的其他基金

Skin Vaccination Against Influenza in the Young And Aged
年轻人和老年人的流感皮肤疫苗接种
  • 批准号:
    9210049
  • 财政年份:
    2015
  • 资助金额:
    $ 10.81万
  • 项目类别:
Skin Vaccination Against Influenza in the Young And Aged
年轻人和老年人的流感皮肤疫苗接种
  • 批准号:
    8886505
  • 财政年份:
    2015
  • 资助金额:
    $ 10.81万
  • 项目类别:
A dual vaccine strategy against filovirus infection
针对丝状病毒感染的双重疫苗策略
  • 批准号:
    8257884
  • 财政年份:
    2011
  • 资助金额:
    $ 10.81万
  • 项目类别:
A dual vaccine strategy against filovirus infection
针对丝状病毒感染的双重疫苗策略
  • 批准号:
    8650780
  • 财政年份:
    2011
  • 资助金额:
    $ 10.81万
  • 项目类别:
A dual vaccine strategy against filovirus infection
针对丝状病毒感染的双重疫苗策略
  • 批准号:
    8463750
  • 财政年份:
    2011
  • 资助金额:
    $ 10.81万
  • 项目类别:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC)
流感发病机制
  • 批准号:
    8357468
  • 财政年份:
    2011
  • 资助金额:
    $ 10.81万
  • 项目类别:
A dual vaccine strategy against filovirus infection
针对丝状病毒感染的双重疫苗策略
  • 批准号:
    8076663
  • 财政年份:
    2011
  • 资助金额:
    $ 10.81万
  • 项目类别:
A dual vaccine strategy against filovirus infection
针对丝状病毒感染的双重疫苗策略
  • 批准号:
    8837557
  • 财政年份:
    2011
  • 资助金额:
    $ 10.81万
  • 项目类别:
VLP VACCINES FOR HIV PREVENTION
用于预防 HIV 的 VLP 疫苗
  • 批准号:
    8357486
  • 财政年份:
    2011
  • 资助金额:
    $ 10.81万
  • 项目类别:
Design of HIV VLPs with Enhanced Immunogenicity
具有增强免疫原性的 HIV VLP 的设计
  • 批准号:
    8278665
  • 财政年份:
    2010
  • 资助金额:
    $ 10.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了